These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 11093887)

  • 1. [Invasive fungal infections in patients with hematological malignancies: a clinical approach].
    García-Ruiz JC; Pontón J
    Med Clin (Barc); 2000 Sep; 115(8):305-12. PubMed ID: 11093887
    [No Abstract]   [Full Text] [Related]  

  • 2. [Mycoses and their treatment in malignant hemopathies].
    Martino P; Girmenia C
    Recenti Prog Med; 1999 Mar; 90(3):160-8. PubMed ID: 10228357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Considerations in the approach to invasive fungal infection in patients with haematological malignancies.
    Bow EJ
    Br J Haematol; 2008 Jan; 140(2):133-52. PubMed ID: 18173752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antifungal therapy in 'bone marrow failure'.
    Richardson MD; Kokki MH
    Br J Haematol; 1998 Mar; 100(4):619-28. PubMed ID: 9531326
    [No Abstract]   [Full Text] [Related]  

  • 5. Fungal infection from Fusarium spp. in children with refractory hematologic malignancies.
    Taçyildiz N; Yavuz G; Unal E; Gözdasoğlu S; Ertem M; Aysev D
    Med Pediatr Oncol; 1999 Dec; 33(6):596-7. PubMed ID: 10573590
    [No Abstract]   [Full Text] [Related]  

  • 6. Fungal infections in nontransplant patients with hematologic malignancies.
    Segal BH; Bow EJ; Menichetti F
    Infect Dis Clin North Am; 2002 Dec; 16(4):935-64, vii. PubMed ID: 12512188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of mycoses in patients with hematologic disease and cancer -- review of the literature.
    Ruhnke M; Maschmeyer G
    Eur J Med Res; 2002 May; 7(5):227-35. PubMed ID: 12069913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fungal infections in immunocompromised patients.
    Sganga G
    Mycoses; 2011 Dec; 54 Suppl 4():1-3. PubMed ID: 22126521
    [No Abstract]   [Full Text] [Related]  

  • 9. Disseminated Ochroconis gallopavum infection in a chronic lymphocytic leukemia: a case report and review of the literature on hematological malignancies.
    Fukushima N; Mannen K; Okamoto S; Shinogi T; Nishimoto K; Sueoka E
    Intern Med; 2005 Aug; 44(8):879-82. PubMed ID: 16157992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology and treatment outcome of invasive fungal infections in patients with hematological malignancies.
    Kurosawa M; Yonezumi M; Hashino S; Tanaka J; Nishio M; Kaneda M; Ota S; Koda K; Suzuki N; Yoshida M; Hirayama Y; Takimoto R; Torimoto Y; Mori A; Takahashi T; Iizuka S; Ishida T; Kobayashi R; Oda T; Sakai H; Yamamoto S; Takahashi F; Fukuhara T
    Int J Hematol; 2012 Dec; 96(6):748-57. PubMed ID: 23111539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant interferon gamma1b immune enhancement in 20 patients with hematologic malignancies and systemic opportunistic infections treated with donor granulocyte transfusions.
    Safdar A; Rodriguez GH; Lichtiger B; Dickey BF; Kontoyiannis DP; Freireich EJ; Shpall EJ; Raad II; Kantarjian HM; Champlin RE
    Cancer; 2006 Jun; 106(12):2664-71. PubMed ID: 16691620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Invasive fungal infections in paediatric patients.
    Roilides E; Walsh TJ
    Clin Microbiol Infect; 2010 Sep; 16(9):1319-20. PubMed ID: 20678174
    [No Abstract]   [Full Text] [Related]  

  • 13. [Trends of invasive fungal infections in hematological malignancies and new antifungal agents].
    Mori T
    Rinsho Ketsueki; 2003 Jan; 44(1):8-13. PubMed ID: 12649831
    [No Abstract]   [Full Text] [Related]  

  • 14. Introduction to the updated Australian and New Zealand consensus guidelines for the use of antifungal agents in the haematology/oncology setting, 2008.
    Slavin MA
    Intern Med J; 2008 Jun; 38(6b):457-67. PubMed ID: 18588519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Invasive infection due to Trichosporon cutaneum in patients with hematologic malignancies.
    Kataoka-Nishimura S; Akiyama H; Saku K; Kashiwa M; Mori S; Tanikawa S; Sakamaki H; Onozawa Y
    Cancer; 1998 Feb; 82(3):484-7. PubMed ID: 9452265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breakthrough invasive fungal infections: Who is at risk?
    Jenks JD; Cornely OA; Chen SC; Thompson GR; Hoenigl M
    Mycoses; 2020 Oct; 63(10):1021-1032. PubMed ID: 32744334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in the management of fungal infections.
    Muñoz P; Valerio M; Vena A; Bouza E; Posteraro B; Lass-Flörl C; Sanguinetti M
    Mycoses; 2015 Jun; 58 Suppl 2():1. PubMed ID: 26033250
    [No Abstract]   [Full Text] [Related]  

  • 18. [Prophylaxis of fungal infections in haematological patients: pro].
    Glass B
    Dtsch Med Wochenschr; 2010 Sep; 135(38):1870. PubMed ID: 20842607
    [No Abstract]   [Full Text] [Related]  

  • 19. Management of systemic Fusarium infection in children with leukemia.
    Ariffin H; Ariffin W; Mohamed M; Arasu A; Peng LH
    Med Pediatr Oncol; 1999 Dec; 33(6):598-9. PubMed ID: 10573592
    [No Abstract]   [Full Text] [Related]  

  • 20. Empirical versus preemptive antifungal therapy for high-risk, febrile, neutropenic patients: a randomized, controlled trial.
    Cordonnier C; Pautas C; Maury S; Vekhoff A; Farhat H; Suarez F; Dhédin N; Isnard F; Ades L; Kuhnowski F; Foulet F; Kuentz M; Maison P; Bretagne S; Schwarzinger M
    Clin Infect Dis; 2009 Apr; 48(8):1042-51. PubMed ID: 19281327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.